Guardant Health
GH
#3559
Rank
HK$24.06 B
Marketcap
HK$195.58
Share price
-1.18%
Change (1 day)
-8.80%
Change (1 year)
Guardant Health is an American company developing blood tests for early detection in high-risk populations and recurrence monitoring in cancer survivors.

Market capitalization of Guardant Health (GH)

Market cap: HK$24.06 Billion

As of September 2024 Guardant Health has a market cap of HK$24.06 Billion. This makes Guardant Health the world's 3559th most valuable company by market cap according to our data. The market capitalization, commonly called market cap, is the total market value of a publicly traded company's outstanding shares and is commonly used to measure how much a company is worth.

Market cap history of Guardant Health from 2018 to 2024

End of year Market Cap

Year Market cap Change
2024HK$24.06 B-6.17%
2023HK$25.64 B17.79%
2022HK$21.76 B-72.54%
2021HK$79.28 B-20.64%
2020HK$99.90 B74.8%
2019HK$57.15 B126.42%
2018HK$25.24 B

End of Day market cap according to different sources

On Sep 20th, 2024 the market cap of Guardant Health was reported to be:

HK$24.06 Billion
by Yahoo Finance info icon info icon
HK$24.06 Billion
by CompaniesMarketCap info icon info icon
HK$24.06 Billion
by Nasdaq info icon info icon

Market capitalization for similar companies or competitors

Name Market cap Market cap differencediff. Country
HK$123.19 B 412.01%๐Ÿ‡บ๐Ÿ‡ธ USA
HK$29.49 B 22.58%๐Ÿ‡บ๐Ÿ‡ธ USA